Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -0.3% | -50.4% | 1 / 3 | +11.8% | -1.04 pp | -1.70 pp | +7.8% | 0.14 | 21.23 | 78,3 | +11,8% | 11,0 | −0,3% | 21.23 | 10.78 | +96,9% |
| Pts | 0 | 0 | 4 | 4 | 4 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 19.400 (close price on 2026-08-06)EPS (TTM): 913,9
Financial charts
1.Revenue & growth
VND bn78,3Q2/26
1.Revenue & growth
VND bn78,3Q2/26
2.Profit & growth
VND bn11,3Q2/26
3.Profit mix (Penman)
VND bn35,5Q2/26
4.Margins & cost structure
%34.9%Q2/26
5.Returns & cash cycle
% · days8.3%Q2/26
6.Earnings quality & cash
VND bn151Q2/26
7.Asset structure
VND bn611Q2/26
8.Funding & debt health
VND bn · times611Q2/26
9.Revenue backlog
VND bn2,68Q2/26
10.Valuation
times · %21,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %329Q2/26
Adjusted EPS growth, latest quarter
2.5%
Average adjusted EPS growth, 3 quarters
1.3%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26